Oncogenicity of lncRNA FOXD2-AS1 and its molecular mechanisms in human cancers.
CONCLUSIONS: LncRNA FOXD2-AS1 is an oncogene and probably represents a feasible biomarker or therapeutic target in human cancers.
PMID: 30723052 [PubMed - as supplied by publisher]
Source: Pathology, Research and Practice - Category: Pathology Authors: Hu Q, Tai S, Wang J Tags: Pathol Res Pract Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Colorectal Cancer | Databases & Libraries | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Molecular Biology | Nasopharyngeal Cancer | Pathology | Science | Skin | Skin Cancer | Study | Thyroid | Thyroid Cancer